PYOTT DAVID E I

CIK 00010515787 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001051578

Recent Transactions

50 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-06-25+3,837→ 3,837 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-25+806→ 806 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-06-25+2,417→ 2,417 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01$300.72/sh−495→ 1,599 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01+3,830→ 5,412 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01$299.87/sh−1,222→ 2,094 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2026-06-01−3,830→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01$302.65/sh−17→ 1,582 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01$297.71/sh−921→ 4,491 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-06-01$298.91/sh−1,175→ 3,316 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-05-20+671→ 1,582 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2026-05-20+1,441→ 1,441 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-04-24+1,383→ 1,383 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-04-24−1,383→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-02-18+5,893→ 5,893 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-02-18+3,729→ 3,729 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2025-06-05+30,000→ 30,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 911 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-03-24−7,440→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-24$88.95/sh+7,440→ 7,576 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-24$299.00/sh−7,440→ 136 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$221.00/sh−7,420→ 7,606 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$71.99/sh+7,470→ 32,586 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$88.95/sh+17,560→ 17,696 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$222.00/sh−7,470→ 136 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$220.00/sh−17,560→ 15,026 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-24$70.20/sh+7,420→ 25,116 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−17,560→ 7,440 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−7,470→ 3,780 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-24−7,420→ 3,830 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2024-06-13+26,764→ 26,764 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 49,750 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-16+5,228→ 5,228 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-07+14,000→ 14,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-05-23+4,190→ 45,030 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-23+136→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-23−136→ 0 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-06-16+15,000→ 15,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-05-24+4,980→ 40,840 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-05-18+5,153→ 5,153 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2022-02-23+136→ 136 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-07-15+4,032→ 4,032 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-06-29+13,286→ 13,286 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-06-29+13,286→ 13,286 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-05-25+5,120→ 35,860 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-01-12+26,573→ 26,573 total
Purchase
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-08-31$78.84/sh+900→ 30,740 total
Purchase
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-08-31$78.22/sh+11,900→ 29,840 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618

View on SEC.gov